AEGiS-FDA: ACTIS and ATIS merge into single website - http://www.AIDSinfo.nih.gov Food and Drug AdministrationImportant note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Click here to return to FDA main menu
DonateNow


ACTIS and ATIS merge into single website - http://www.AIDSinfo.nih.gov

Food and Drug Administration - December 1, 2002
Richard Klein, Office of Special Health Issues

On December 2, 2002, the HIV/AIDS Clinical Trials Information Service (ACTIS) and its sister service, the HIV/AIDS Treatment Information Service (ATIS), will be merged into a single website called http://www.AIDSinfo.nih.gov. The AIDSinfo project will include all of the services already available from ACTIS and ATIS, as well as added quick and easy access to wide-ranging Federal resources on HIV/AIDS clinical research, HIV treatment and prevention, and medical practice guidelines for health care providers and consumers.

The AIDSinfo Web site, located at http://www.AIDSinfo.nih.gov, is designed for full accessibility, ensuring easy search and navigation. The Web site presents federally approved information on HIV/AIDS treatment and prevention guidelines, a comprehensive database of both government and industry-supported HIV/AIDS clinical trials, and information about approved and experimental HIV/AIDS drugs, and vaccines. The site's Education and Resource Center is a virtual one-stop shop offering links and other downloadable resources specially designed for patients, researchers, health care providers, and the general public.

An AIDSinfo Telephone Help Line will provide access to English- and Spanish-speaking Health Information Specialists who offer confidential responses to questions, and assistance with navigating the Web site. The Help Line is available Monday through Friday, noon to 5:00 p.m., Eastern Time.

Telephone: 800-448-0440

International: 301-519-0459

TTY/TDD: 888-480-3739

E-mail: ContactUs@aidsinfo.nih.gov

AIDSinfo E-news, an electronic newsletter, will keep you informed about new and updated treatment guidelines, clinical trials, drugs, and Web site updates. If you already subscribe to the ATIS listserv, you will automatically be placed on the AIDSinfo E-news subscriber list. If not, please visit the AIDSinfo Web site on or after December 2 to subscribe.

Plan to visit the AIDSinfo Web site on or after December 2, or call to learn more about this exciting new service.
021201
FD021201

SOURCE: Food and Drug Administration (FDA).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, the Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .